News on CE Elantech%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated CE Elantech%2C Inc. news from BioPortfolio.com Wed, 10 Feb 2010 08:03:20 GMT en St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040097&HITNO=0&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040097&THISHREF=http://c.moreover.com/click/here.pl%3fz2538587504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040097&HITNO=0&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040097&THISHREF=http://c.moreover.com/click/here.pl%3fz2538587504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: ::: Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039408&HITNO=1&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039408&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039408&HITNO=1&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039408&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Ikonisys to showcase oncoFISH cervical test at Eurogin 2010 Cervical Cancer Prevention Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039855&HITNO=2&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039855&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039855&HITNO=2&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039855&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: PicksThatMove.com Announces Investment Opinion on Western Coal Corp., Arco Resources Corp., Rexahn Pharmaceuticals Inc, Cord Blood America Inc. and Cehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036992&HITNO=3&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036992&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036992&HITNO=3&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036992&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Endo Pharmaceuticals Completes Secondary Offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=4&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=4&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCitybizlist: OncoVista OVIT.OB Subsidiary Inks Exclusive Agreement with TATAA Molecular Diagnosticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034640&HITNO=5&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034640&THISHREF=http://c.moreover.com/click/here.pl%3fz2535903186%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034640&HITNO=5&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034640&THISHREF=http://c.moreover.com/click/here.pl%3fz2535903186%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035736&HITNO=6&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035736&THISHREF=http://c.moreover.com/click/here.pl%3fz2536349783%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035736&HITNO=6&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035736&THISHREF=http://c.moreover.com/click/here.pl%3fz2536349783%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Thermo Fisher Scientific Introduces New High-quality IVF Consumableshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035309&HITNO=7&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035309&THISHREF=http://c.moreover.com/click/here.pl%3fz2536191808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035309&HITNO=7&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035309&THISHREF=http://c.moreover.com/click/here.pl%3fz2536191808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Thermo Fisher Scientific Introduces New High-quality IVF Consumableshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035273&HITNO=8&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035273&THISHREF=http://c.moreover.com/click/here.pl%3fz2536178392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035273&HITNO=8&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035273&THISHREF=http://c.moreover.com/click/here.pl%3fz2536178392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRLog: Delcath Signs First Partner Agreement in Asiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036946&HITNO=9&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036946&THISHREF=http://c.moreover.com/click/here.pl%3fz2536838474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036946&HITNO=9&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036946&THISHREF=http://c.moreover.com/click/here.pl%3fz2536838474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034888&HITNO=10&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034888&THISHREF=http://c.moreover.com/click/here.pl%3fz2536026423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034888&HITNO=10&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034888&THISHREF=http://c.moreover.com/click/here.pl%3fz2536026423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035887&HITNO=11&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536414013%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035887&HITNO=11&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536414013%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: St Jude Medical gains EU approval for high power ICD and CRT-D deviceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038564&HITNO=12&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038564&THISHREF=http://c.moreover.com/click/here.pl%3fz2537657815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038564&HITNO=12&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038564&THISHREF=http://c.moreover.com/click/here.pl%3fz2537657815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMTB Europe: Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Preventihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037022&HITNO=13&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037022&THISHREF=http://c.moreover.com/click/here.pl%3fz2536860754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037022&HITNO=13&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037022&THISHREF=http://c.moreover.com/click/here.pl%3fz2536860754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at thttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036963&HITNO=14&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536845046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036963&HITNO=14&MSIZE=553&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CE%20Elantech,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536845046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDBusinessNews.com: